You are here: Industry Insights > oncology

News List

Top 10 Small Molecule Drugs: A Half were Oncology Drugs PharmaSources/Yuntian
April 24, 2019
Small molecule drugs still have a huge share in the global market at present, and are the biggest source of drugs.
FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer drugs
April 17, 2019
FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer.
Evotec & Indivumed Enter Research Collaboration ontractpharma
April 15, 2019
To discover and develop first-in-class therapeutics for the treatment of colorectal cancer.
ESMO drives EU-level action to tackle shortages of essential medicines europeanpharmaceuticalreview
April 12, 2019
Shortages of inexpensive, essential medicines: calling for tangible political commitments in the EU…
Concerto HealthAI collaborates with Pfizer for precision oncology biospectrumasia
April 11, 2019
A Concerto HealthAI-Pfizer joint steering committee will oversee the collaboration. The first outcomes research and publications are expected in early 2020.
Boehringer Ingelheim enhances oncology R&D with novel MacroDel delivery technology via acquisition of ICD Therapeutics worldpharmanews
April 10, 2019
Boehringer Ingelheim enhances oncology R&D with novel MacroDel delivery technology via acquisition of ICD Therapeutics...
Boehringer Ingelheim enhances oncology R&D with novel MacroDel delivery technology via acquisition of ICD Therapeutics worldpharmanews
April 08, 2019
Boehringer Ingelheim announced that it acquired ICD Therapeutics. The acquisition includes rights to ICD's innovative MacroDel biologics-delivery platform.
SpringWorks Therapeutics raises $125m for rare oncology programmes pharmaceutical-technology
April 03, 2019
US-based SpringWorks Therapeutics, which specialises on developing medicines and treatments for cancers and severe rare diseases, has raised $125m in a series B funding round led by Perceptive Advisors.
SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer pharmafocusasia
March 20, 2019
SOTIO, a biotechnology company owned by the PPF Group, presented results from SOV02, its Phase II clinical trial evaluating DCVAC/OvCa, an active cellular immunotherapy product, in patients with recurrent ovarian cancer at 2019 SGO’s 50th Annual Meeting o
Notable Labs brings on 2 development executives ahead of its first blood cancer trials fiercebiotech
February 27, 2019
After launching its first in-house R&D program last month, cancer drug-testing startup Notable Labs has brought on two biopharma executives to take charge of its clinical operations and drug development work....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page